Bayer plans $2.2 billion pharmaceutical facility in US
German company Bayer has announced plans to invest $2.2 billion (€1.95 billion) in a new pharmaceutical production facility in the United States.
The planned investment comes amid pressure from US President Donald Trump’s administration on pharmaceutical companies to increase manufacturing on American soil.
Bayer’s announcement places the company among the drugmakers responding to a policy environment increasingly focused on domestic production. The information provided does not establish whether the administration’s pressure directly prompted the investment.
No location, construction timetable or details of the medicines to be produced at the new facility were included in the announcement summary.
This is an automated summary from the available headline and excerpt, not the full story or a claim of human review.
Latest Arab & World — refreshed every 30 minutes
News refreshes automatically every 30 minutes. Every headline opens inside Trend Masr.